Data Shows Decrease in Cancer and Disease Diagnoses Continued in Pandemic’s Second Year
Dancer diagnoses in the U.S. remained below pre-pandemic levels in 2021, with fewer early-stage and late-stage diagnoses compared to 2020.
Read MorePosted by Andy Lundin | Sep 23, 2024 | Cancer |
Dancer diagnoses in the U.S. remained below pre-pandemic levels in 2021, with fewer early-stage and late-stage diagnoses compared to 2020.
Read MorePosted by Andy Lundin | Sep 23, 2024 | Molecular Diagnostics |
A study on recessive genetic contributions to developmental disorders found that most undiagnosed cases are linked to known genes.
Read MorePosted by Andy Lundin | Sep 20, 2024 | Diabetes & Metabolic Diseases |
The blood test uses lipid analysis to identify warning signs of metabolic diseases like diabetes, liver, and heart disease in children.
Read MorePosted by Andy Lundin | Sep 18, 2024 | Molecular Diagnostics |
Pillar Biosciences and AstraZeneca seek to expand access to NGS-based liquid biopsy tumor profiling to detect genetic cancer variants.
Read MorePosted by Andy Lundin | Sep 18, 2024 | Diabetes & Metabolic Diseases |
A new study encourages the use of more reliable tests to prevent pregnancy complications and the development of type II diabetes.
Read More